This dysregulation culminates in the hyperactivation of AURKA, enabling its interaction with multiple proteins, including oncogenes and tumour suppressor genes, thereby fostering the development and progression of HCC.92, 93, 94, 95. The gene discussed is AURKA; the disease is hepatocellular carcinoma.